CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 26, 2006--Biogen Idec Inc. (NASDAQ: BIIB - News), a global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, today reported its first quarter 2006 results.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 26, 2006--Biogen Idec Inc. (NASDAQ: BIIB - News), a global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, today reported its first quarter 2006 results.
